News

The CDC suggests that disrupted access to ADHD medications may increase risk of overdose and injury.

Do physical health conditions in childhood affect ADHD symptoms at age 17 years? Researchers investigated these associations in a large cohort study.

"...when skilled hands and callused fingertips pick sweet equations where practice becomes song."

These 2 perspectives, one from ancient religious faith sources and the other from modern substantiating scientific research, gives H. Steven Moffic, MD, hope that psychoexemplaries have mental health value.

Following the vote of the US Food and Drug Administration Psychopharmacologic Drugs Advisory Committee, Lykos has released a statement on MDMA-assisted therapy.

Providing palliative care to patients with anorexia nervosa.

"Hear the story of wood, cut and stained and carved for someone’s need."

What does being a humanitarian mean to H. Steven Moffic, MD, winner of the 22024 Abraham L. Halpern Humanitarian Award?

"An ounce of prevention is worth a pound of cure."

Recent research sheds light on which antidepressants should be preferred as a first option for long-term use.

Expanding the medical model to embrace the humanities.

With cannabis legalization increasing in the United States, so too are the issues surrounding cannabis access, usage, and use disorders. State by state, take a peek at some of the issues and updates surrounding cannabis.

In this 2-part series, a psychiatrist explores the connections between hostage films and psychiatry.

Not all alone time is the same...

Transgender individuals are 4 times as likely as their cisgender peers to have a mental illness. Check out these culturally competent care strategies and tips to provide the best possible care.

Experts shared the study results in a poster presentation at the 2024 ASCP Annual Meeting.

The FDA Advisory Committee recommended donanemab, which could lead to its approval later this year.

Here are 5 reasons why we need to study the history of psychiatry.

The Psychiatric Times Editor-in-Chief discusses the clinical uses and casual prescribing of ketamine for the treatment of psychiatric disorders.

Getting ready to do ketamine-assisted psychotherapy requires a lot of preparation.

Here are highlights from the week in Psychiatric Times.

Investigational agent KarXT is a first-in-class muscarinic receptor agonist demonstrating antipsychotic efficacy and safety in short- and long-term clinical trials.

What is new in research on schizophrenia?

Social media content moderation: a brief for clinicians.

We're highlighting issues in addiction in our special Digital Supplement! Learn more here.

"Touched by the hard times, flowers shed tears. Grieved by separations, birds are startled in their hearts."

Experts shared the study results in a poster presentation at the 2024 ASCP Annual Meeting.

An expert discusses how the risks of benzodiazepine prescribing have been exaggerated in the minds of government officials, critics, and the public at large.

H. Steven Moffic, MD, interviews Neil Krishan Aggarwal, MD, MBA, MA, DFAPA, on his new book and the concept of peacemaking.

Physician-assisted suicide is now legal in 11 jurisdictions in the US. To this, several clinicians say: “We must care for the dying, not make them dead.” Learn more in our June cover story.